WHO Says No to Artificial Sweeteners for Weight Loss
17 May 2023
WEDNESDAY, May 17, 2023 -- Sugar substitutes are not effective for weight loss and may also cause harm, warns the World Health Organization.
Long-term use of sugar substitutes may cause "potential undesirable effects," according to new WHO guidance. This can include an "increased risk of type 2 diabetes, cardiovascular diseases, and mortality in adults."
Consuming foods and beverages with ingredients like saccharin or sucralose or adding them to foods "does not confer any long-term benefit in reducing body fat in adults or children," the WHO said after completing a systematic review.
Among the artificial sweeteners WHO officials considered were acesulfame K, aspartame, advantame, cyclamates, neotame, saccharin, sucralose, stevia, and stevia derivatives.
"People need to consider other ways to reduce free sugars intake, such as consuming food with naturally occurring sugars, like fruit, or unsweetened food and beverages," said Francesco Branca, WHO director for nutrition and food safety. Artificial sweeteners "are not essential dietary factors and have no nutritional value. People should reduce the sweetness of the diet altogether, starting early in life, to improve their health."
These recommendations do not apply to people who already have diabetes. That group was not included in the review.
More Information
Posted May 2023
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
-Targets
-Drugs
Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.